Fogorvosi szemle, 2006 (99. évfolyam, 1-6. szám)

2006-10-01 / 5. szám

FOGORVOSI SZEMLE 99. évf. 5. sz. 2006. 211 A prospective double blind trial of chlorhexidine. Bone Marrow Trans­plant 1988; 3: 483-494. 11. Fiddian-Green R, Baker S: Nosocomial pneumonia in the critical­ly ill: Product of aspiration or translocation? Crit Care Med 1991 ; 19: 763-769. 12. Finegold SM: Aspiration pneumonia. Rev Infect Dis 1991; 13: S737-S742. 13. Fog- és Szájbetegségek Szakmai Kollégiuma: Módszertani levelek és ajánlások gyűjteménye. In: Módszertani ajánlás: Infekciókontroll a fogorvosi rendelőben. Budapest, 2002; 75-90. 14. Fourrier F, Duvivier B, Boutigny H, Roussel-Delvallez M, Chopin C: Colonization of dental plaque: a source of nosocomial infections in intensive care unit patients. Crit Care Med 1998; 26: 301-308. 15. Frandsen EG, Reinholdt J, Kilian M: Enzymatic and antigenic characterization of immunglobulin A1 proteases from Bacteroides and Capnocytophaga spp. Infect Immun 1987; 55: 631-638. 16. Gibbons RJ, Etherden I: Fibronectin-degrading enzymes in sa­liva and their relation to oral cleanliness. J Periodont Res 1986; 21: 386-395. 17. Gibbons RJ, Hay Di, Childs WC, Davis G: Role of cryptic recep­tors (criptitopes) in bacterial adhesion to oral surfaces. Arch Oral Bi­­ol 1990; 35 (suppi); 107S-114S. 18. Goldstein EJ, Kirby BD, Finegold SM: Isolation of Eikenella corr­odens from pulmonary infections. Am Rev Respir Dis 1979; 119: 55-58. 19. Harvard School of Public Health, Boston, Massachusetts, US: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276. 20. Hayes C, Sparrow D, Cohen M, Vokonas P, Garcia Rl: Period­ontal disease and pulmonary function: the VA longitudinal study. Ann Periodontol 1998; 3: 257-261. 21. Joshi N, O'Bryan T, Appelbaum PC: Pleuropulmonary infections caused by Eikenella corrodens. Rev Infect Dis 1991; 13: 1207-1212. 22. Karuza J, Miller WA, Lieberman D, Ledenyi L, Thines T: Oral status and resident well-being in a skilled nursing facility population. Ge­rontologist 1992; 32: 104-112. 23. Kiyak HA, Grayston MN, Crinean CL: Oral health problems and needs of nursing home residents. Commun Dent Oral Epidemiol 1993; 21: 49-52. 24. Kjeldsen M, Holmstrup P, Lindermann RA, Bendtzen K: Bacterial­­stimulated cytokin production of peripheral mononuclear cell from patients of various periodontitis categories. J Periodontol 1995; 66: 139-144. 25. Klekner Á, Gáspár A, Karoos S, Szabó J, Csecsei Gy: Cefazolin prophylaxis in neurosurgery monitored by capillary electrophoresis. J Neurosurg Anesthesiol 2003; 15 (3): 249-54. 26. Komiyama K, Tynan JJ, Habbick BF, Duncan DE, Liepert DJ: Pseu­domonas aeruginosa in the oral cavity and sputum of patient with cystic fibrosis. Oral Surg Oral Med Oral Pathol 1985; 59: 590-594. 27. Lang NP, Brecx MC: Chlorhexidine gluconate - An agent for chemical plaque control and prevention of gingival inflammation. J Periodont Res 1986; 21 (suppl 16): 74-89. 28. Levison ME: Pneumonia, including necrotizing pulmonary infec­tions (Lung abscess). In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL eds.: Harrison's Principles of Inter­national Medicine. New York: McGraw-Hill, 1994: 1184-1191. 29. Loesche WJ, Syed SA, Stoll J: Trypsin-like activity in subgingival plaque. A diagnostic marker for spirochetes and periodontal disease. J Periodontol 1987; 58: 266-273. 30. Lorenz KA, Weiss PJ: Capnocytophagal pneumonia in a healthy man. West J Med 1994; 160: 79-80. 31. Mahomed AG, Feldman C, Smith C, Promnitz DA, Kaka S: Does primary Streptococcus viridans pneumonia exist? S Afr Med J 1992; 82: 432-434. 32. Marik Pe, Careau P: The role of anaerobes in patients with ventillator-associated pneumonia and aspiration pneumonia: a pros­pective study. Chest 1999; 115: 178-183. 33. Megran GW, Chow AW: Bacterial aspiration and anaerobic pleuro­pulmonary infections. In: Sande MA, Hudson LD, Root RK eds.: Res­piratory Infections. New York : Churchill Livingstone; 1986: 269- 292. 34. Mier L, Dreyfuss D, Darchy B, et al: Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected speciment brush and quantitative cultures. Inten­sive Care Med 1993; 19: 279-284. 35. Nakamura M, Slots J. Salivary enzymes. Origin and relatioinship to periodontal disease. J Periodont Res 1983; 18: 559-569. 36. Quinn MO, Miller VE, Dal Nogare AR: Increased salivary exogly­­cosidase activity during critical illness. Am J Resp Crit Care Med 1994;150:179-183. 37. Radford JR, Homer KA, Naylor MN, Beighton D: Inhibition of human subgingival plaque protease activity by chlorhexidine. Arch Oral Biol 1992; 37: 245-248. 38. Reddy MS, Murphy TF, Faden HS, Bernstein JM: Middle ear mucin glicoprotein : purification and interaction with nontypable Haemophilus influenzae and Moraxella catarrhalis. Otolaryngol Head Neck Surg 1997; 116:175-180. 39. Rossomando EF, White L: A novel method for the detection of TNF-0 in gingival crevicular fluid. J Periodontol 1993; 64: 445-449. 40. Russel SL, Scannapieco FA, Boylan RJ, Kaslick RS, Katz RV: Respiratory pathogen colonization of the dental plaque of institutio­nalized elders. Spec Care Dent 1999; 19: 128-134. 41. Scannapieco FA, Mylotte JM: Relationships between periodontal disease and bacterial pneumonia. J Periodontol 1996; 67:1114-1122. 42. Scannapieco FA: Role of oral bacteria in respiratory infection. J Periodontol 1999; 70: 793-802. 43. Scannapieco FA. Stewart EM, Mylotte JM: Colonization of dental plaque by respiratory pathogens in medical intensive care patients. Crit Care Med 1992; 20: 740-745. 44. Schreiner A: Anaerobic pulmonary infections. Scand J Infect Dis 1979; 19 (Suppl.): 77-79. 45. Spijkervet FKL, Saene HKFV, Saene JJMV, et al: Effect of selec­tive elimination of the oral flora on mucositis in irradiated head and neck cancer patient. J Surg Oncol 1991; 46: 167-173. 46. Suwanagool S, Rothkopf MM, Smith SM, LeBlanc D: Pathogen­icity of Eikenella corrodens in humans. Arch Intern Med 1983; 143: 2265-2268. 47. Svanborg C, Hedlund M, Connell H, et al: Bacterial adherence and mucosal cytokine responses. Receptors and transmembrane signalling. Ann NY Acad Sciences 1996; 797: 177-190. 48. Tatakis DN: lnterleukin-1 and bone metabolism: a review. J Per­­iodontol 1993; 64: 416-431. 49. The American Academy of Periodontology. Periodontal disease as a potential risk factor for systemic diseases (position paper). J Periodontol 1998; 69: 841-850. 50. The Japanase Respiratory Society. Aspiration pneumonia. The commitee for The Japanase Respiratory Society giudelines in mana­gement of respiratory infections. Respirology 2004; 9: S35-S37. 51. Toews GB: Nosocomial pneumonia. Am J Med Sei 1986; 291: 355-367. 52. Tonelli PM, Hume WR, Kenney EB: Chlorhexidine: A review of the literature. J West Soc Periodontol Periodont Abstr 1983; 31: 5-30. 53. Weinmeister KD, Dal Nogare AR: Buccal cell carbohydrates are altered during critical illness. Am J Resp Crit Care Med 1994; 150: 131-134. 54. Wikström M, Linde A: Ability of oral bacteria to degrade fibro­­nectin. Infect Immun 1986; 51: 707-711. 55. Wilson M, Reddi K, Henderson B: Cytokine-inducing components of periodontopathogenic bacteria. J Periodont Res 1996; 31: 393-407. 56. Yuan A, Luh KT, Yang PC: Actinobacillus actinomycetemcomitans pneumonia with possible septic embolization (letter to the Editor). Chest 1994; 105: 646. 57. Zambon JJ, Nakamura M, Slots J: Effect of periodontal therapy on salivary enzyme activity. J Periodont Res 1985; 20: 652-659. 58. Zijlstra EE, Swart GR, Godfroy FJM, Degener JE: Pericarditis, pneumonia and brain abscess due to a combined Actinomyces- Actinobacillus actinomycetemcomitans infection. J Infect 1992; 25: 83-87.

Next

/
  • Elrendezés
  • Igazítás
  • Forgatás
Oldalképek
Tartalom